本页面由Tiger Trade Technology Pte. Ltd.提供服务

Fennec Pharmaceuticals Inc.

10.18
-0.5400-5.04%
盘后:10.180.00000.00%19:30 EDT
成交量:23.16万
成交额:236.04万
市值:3.57亿
市盈率:-84.83
高:10.75
开:10.72
低:10.09
收:10.72
52周最高:13.25
52周最低:5.65
股本:3,506.72万
流通股本:1,988.67万
量比:2.31
换手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-0.1200
每股收益(LYR):-0.3409
净资产收益率:-18.58%
总资产收益率:-1.16%
市净率:8.41
市盈率(LYR):-29.86

数据加载中...

2026/09/18

重要事件披露

Form 8-K - Current report
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/18

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities